Unannounced · 260 daysFiled 31 December 2025
Alpenglow Biosciences, Inc. has sold $3M so far
Alpenglow Biosciences, Inc., a health care company based in Seattle, WA, has sold $3M so far in its debt round, according to a filing dated 31 December 2025.
No public announcement found as of 15 September 2026, 260 days after the filing.
- Filed
- 31 December 2025
- First filed
- 25 March 2024
- Round
- Debt round (amended filing)
- Amount sold
- $3M
- Offering size
- $3M
- Investors so far
- 14
- Based in
- Seattle, WA
- Website
- alpenglowbiosciences.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 27% of the 1,404 tracked raises with an amount filed in 2025, and than 28% of the 141 in health care.
Alpenglow Biosciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 31 Dec 2025 | Amended filing | $3M | This raise |
| 25 Mar 2024 | New filing | $1.8M | This raise |
More with Dynamk Life Sciences on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.